CHRONIC RENAL DISEASE AS A CAUSE OF CARDIOVASCULAR PATHOLOGY

Authors

DOI:

https://doi.org/10.26565/2227-6505-2017-33-13

Keywords:

chronic pyelonephritis, coronary heart disease, arterial hypertension, cardiac failure

Abstract

The issues of etiology of development of cardiac changes in renal dysfunction, diagnostics and establishment of clinical diagnosis are reviewed as illustrated by a clinical case. Recommendations on lifestyle modification and medicament treatment tactics are described.

This clinical case reflects the peculiarities of incessant progression of combined cardio-vascular pathology developed in association with chronic renal disease, as well as diagnostics and treatment methods.

 

Author Biographies

  • Y. E. Kulik, V. N. Karazin Kharkiv National University

    Svobody sq., 6, Kharkiv, 61022, Ukraine

     
  • L. O. Martymianova, V. N. Karazin Kharkiv National University

    Svobody sq., 6, Kharkiv, 61022, Ukraine

     
  • S. V. Rybchynskyi, V. N. Karazin Kharkiv National University

    Svobody sq., 6, Kharkiv, 61022, Ukraine

     
  • H. Yu. Kartvelishviliy, Kharkiv Railway Clinical Hospital No 1 of Brence of «HC» JSC «Ukrzaliznytsia», Kharkiv, Ukraine

    61018, m. Kharkiv, prov. Balakiev, 5

References

Herzog C. Kidney disease in cardiology / C. Herzog // Nephrology Dialysis Transplantation. – 2010. –No 25. – P. 356–360.

Mukhin N.A. Nephrogenic arterial hypertension / N. А. Mukhin, N. A. Kozlovskaia // Doctor. – 2004. –No 10. – P. 4–7.

Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis / [K. Damman, M. Valente, A. Voors, et al]. // European Heart Journal.– 2014. –No 35. – P. 455–469.

Incident atrial brillation and risk of end-stage renal disease in adults with chronic kidney disease / [N. Bansal, D. Fan, C. Y. Hsu, et al]. – 2013. –No 127. – P. 569.

Bagshaw S. Renal replacement therapy: when to start / S. Bagshaw, R. Wald // Contrib Nephrol. – 2011. –No 174. – P. 232–241.

Korotkyi D.V. Arterial hypertension and myocardial hypertrophy at pre-dialysis stage of chronic renal disease and in replacement renal therapy / D.V. Korotkyi, T. I. Makeeva, O. P. Zavaritskaia // Nephrology and Dialysis. – 2009. –No 11. – P. 251–257.

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization / [A. Go, G. Chertow, D. Fan, et al]. // ACC Current Journal Review. – 2004. –No 13. – P. 13.

Chronic kidney disease and cardiovascular risk: Epidemiology, mechanisms, and prevention / [R. T. Gansevoort, R. Correa-Rotter, B. R. Hemmelgarn, et al]. // The Lancet. – 2013. –No 382. – P. 339–352.

Downloads

Published

2017-09-11

How to Cite

CHRONIC RENAL DISEASE AS A CAUSE OF CARDIOVASCULAR PATHOLOGY. (2017). The Journal of V. N. Karazin Kharkiv National University, Series "Medicine", 33, 67-70. https://doi.org/10.26565/2227-6505-2017-33-13

Most read articles by the same author(s)